Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular Response today announced a joint research and development deal with Scripps Genomic Medicine targeting oncology and cardiovascular disease.

The deal calls for Molecular Response to fund up to two discovery programs in the two indications. In return, Scripps will grant the San Diego-based firm exclusive intellectual property rights.

Further financial and other terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.